3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
5
Heart Diseases
3
Carcinoma, Non-Small-Cell Lung
3
Vascular Diseases
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Small Cell Lung Carcinoma
1
Metabolic Diseases
1
Liver Neoplasms
1
Hematologic Neoplasms
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Cancer Therapy-related Cardiovascular Toxicity
1
Interventions
Voriconazole
2
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
glucarpidase
1
denileukin diftitox
1
bismuth tripotassium dicitrate
1
Ofloxacin
1
Metronidazole
1
Methotrexate
1
Levofloxacin
1
Immunotherapy, Adoptive
1
Esomeprazole
1
Dihydrouracil Dehydrogenase (NADP)
1
Clarithromycin
1
CTLA-4 Antigen
1
Antineoplastic Agents
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Drug-Related Side Effects and Adverse Reactions
×
Antineoplastic Agents
×
Clear all
NCT03882580
2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
5,000 enrolled